Mar 30, 2021 3:00:00 PM
Anthony Finbow, CEO of Eagle Genomics, explains how the science of microbiomes will increasingly contribute to pharma research outcomes by providing the missing piece of the puzzle.
Mar 30, 2021 3:00:00 PM
Anthony Finbow, CEO of Eagle Genomics, explains how the science of microbiomes will increasingly contribute to pharma research outcomes by providing the missing piece of the puzzle.